Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | TPMT | P51580 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31131475 | 0.94 | HSD17B10 (0.54) | HSD17B10KDM4EALDH1A1CA1CA2 | |
| SCHEMBL29141732 | 0.88 | HSD17B10 (0.54) | HSD17B10KDM4EALDH1A1CA1CA2 | |
| SCHEMBL1438740 | 0.85 | HSD17B10 (0.52) | HSD17B10KDM4EALDH1A1CA1CA2 | |
| SCHEMBL11044033 | 0.80 | ALDH1A1 (0.48) | HSD17B10KDM4EALDH1A1CA1CA2 | |
| SCHEMBL4359214 | 0.80 | HSD17B10 (0.50) | HSD17B10KDM4EALDH1A1CA1CA2 | |
| SCHEMBL2646567 | 0.77 | HSD17B10 (0.46) | HSD17B10KDM4EALDH1A1CA1CA2 | |
| SCHEMBL27549037 | 0.77 | HSD17B10 (0.52) | HSD17B10KDM4EALDH1A1CA1CA2 | |
| SCHEMBL5589033 | 0.76 | KDM4E (0.45) | HSD17B10KDM4EALDH1A1CA1CA2 | |
| SCHEMBL5702932 | 0.76 | MEN1 (0.54) | HSD17B10KDM4EALDH1A1CA1CA2 | |
| SCHEMBL9333813 | 0.76 | PTPN1 (0.64) | HSD17B10KDM4EALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1089129-B1 | Positive type photosensitive resin composition, process for producing pattern and electronic parts | HITACHI CHEM DUPONT MICROSYS (JP) | 2007-06-13 | — | — | EP | claimed |
| US-6436593-B1 | A POLYIMIDE PRECURSOR OR A POLYOXAZOLE PRECURSOR HAVING A GROUP REPRESENTED BY--OR, ACID GENERATION WITH RADIATION | HITACHI CHEMICAL DUPONT MICROSYSTEMS LTD. (JP) | 2002-08-20 | — | — | US | claimed |
| EP-1089129-A1 | Positive type photosensitive resin composition, process for producing pattern and electronic parts | Hitachi Chemical DuPont MicroSystems Ltd. (JP) | 2001-04-04 | — | — | EP | claimed |
| US-11021441-B2 | High solubility thioether quinones | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2021-06-01 | — | — | US | disclosed |
| US-20200223794-A1 | High Solubility Thioether Quinones | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2020-07-16 | — | — | US | disclosed |
| US-20190055193-A1 | High-Solubility Thioether Quinones | U.S. DEPARTMENT OF ENERGY | 2019-02-21 | — | — | US | disclosed |
| US-9334368-B2 | Polyimide precursor solution composition | UBE INDUSTRIES, LTD. (JP) | 2016-05-10 | — | — | US | disclosed |
| US-20110193016-A1 | POLYIMIDE PRECURSOR SOLUTION COMPOSITION | UBE INDUSTRIES, LTD. (JP) | 2011-08-11 | — | — | US | disclosed |
| US-20090071693-A1 | NEGATIVE PHOTOSENSITIVE MATERIAL AND CIRCUIT BOARD | MITSUI CHEMICALS, INC. (JP) | 2009-03-19 | — | — | US | disclosed |
| EP-1089129-B1 | Positive type photosensitive resin composition, process for producing pattern and electronic parts | HITACHI CHEM DUPONT MICROSYS (JP) | 2007-06-13 | — | — | EP | disclosed |
| US-6482569-B1 | Process for forming a polyimide pattern with photosensitive composition for i-line stepper | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2002-11-19 | — | — | US | disclosed |
| EP-0718696-B1 | Photosensitive polyimide precursor composition | ASAHI CHEMICAL IND (JP) | 2002-01-16 | — | — | EP | disclosed |
| EP-1089129-A1 | Positive type photosensitive resin composition, process for producing pattern and electronic parts | Hitachi Chemical DuPont MicroSystems Ltd. (JP) | 2001-04-04 | — | — | EP | disclosed |
| US-6162580-A | Photosensitive polyimide precursor compositions processable by exposure to short wavelength light | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 2000-12-19 | — | — | US | disclosed |
| EP-0580108-B1 | A photosensitive polyimide composition | ASAHI CHEMICAL IND (JP) | 1997-03-12 | — | — | EP | disclosed |
| EP-0718696-A2 | A photosensitive polyimide composition | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1996-06-26 | — | — | EP | disclosed |
| EP-0580108-A2 | A photosensitive polyimide composition | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1994-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11021441-B2 | High solubility thioether quinones | SQOR, TST, NDUFS3 | HSD17B10 329/4885KDM4E 2805/4885ALDH1A1 277/4885 |
| US-20200223794-A1 | High Solubility Thioether Quinones | SQOR, TST, NDUFS3 | HSD17B10 329/4885KDM4E 2805/4885ALDH1A1 277/4885 |
| US-20190055193-A1 | High-Solubility Thioether Quinones | SQOR, TST, NDUFS3 | HSD17B10 239/4885KDM4E 2750/4885ALDH1A1 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.